Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Brent Taylor a Centre for Community Child
Health, Royal Free and University College Medical School, University
College London Royal Free Campus, London NW3 2PF, b Immunisation Division, Public Health Laboratory Service,
Communicable Disease Surveillance Centre, London NW9 5EQ
Correspondence to: B Taylor b.taylor{at}rfc.ucl.ac.uk
Objectives:
To investigate whether measles, mumps, and rubella (MMR) vaccination is associated with bowel problems and developmental regression in children with autism, looking for evidence
of a "new variant" form of autism.
What is already known on this topic
This postulated association along with media attention has had a major
adverse effect on public confidence in the vaccine Although population studies have shown no association between autism
and MMR vaccine it has been further postulated that various
environmental or genetic cofactors are required for the effect What this study adds
Neither developmental regression nor bowel problems in children with
autism was associated with MMR vaccination No evidence was found for a "new variant" form of autism
Design:
Population study with case note review linked to independently recorded vaccine data.
Setting:
Five health districts in north east London.
Participants:
278 children with core autism and 195 with atypical autism, mainly identified from computerised disability registers and born between 1979 and 1998.
Main outcome measures:
Recorded bowel problems lasting
at least three months, age of reported regression of the child's
development where it was a feature, and relation of these to MMR vaccination.
Results:
The proportion of children with developmental regression (25% overall) or bowel symptoms (17%) did not change significantly (P value for trend 0.50 and 0.47, respectively) during
the 20 years from 1979, a period which included the introduction of MMR
vaccination in October 1988. No significant difference was found in
rates of bowel problems or regression in children who received the MMR
vaccine before their parents became concerned about their development
(where MMR might have caused or triggered the autism with regression or
bowel problem), compared with those who received it only after such
concern and those who had not received the MMR vaccine. A possible
association between non-specific bowel problems and regression in
children with autism was seen but this was unrelated to MMR vaccination.
Conclusions:
These findings provide no support for an
MMR associated "new variant" form of autism with developmental
regression and bowel problems, and further evidence against involvement
of MMR vaccine in the initiation of autism.
A "new variant" form of autism has been hypothesised, associated
with developmental regression and bowel problems and caused or
triggered by the MMR vaccination
The proportion of children with autism who had developmental regression
or bowel problems has not changed over the 20 years from 1979
Read all Rapid Responses